1834 Investment Advisors’s Medifast MED Stock Holding History

1834 Investment Advisors’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-36	Closed	-$5K	–	449
2020 Q2	$5K	Buy	+36	New	+$3.31K	﹤0.01%	377

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

1834 Investment Advisors's MED Position: Q3 2020 in Review

1834 Investment Advisors sold out of Medifast (MED) in Q3 2020, closing a stake of 36 shares — an estimated $5K sold.

1834 Investment Advisors first reported a position in MED in Q2 2020 and held it in 1 quarter. The position peaked at $5K in Q2 2020. 240 funds tracked by Wall St. Rank hold MED as of Q3 2020.

1834 Investment Advisors reported no remaining Medifast position as of Q3 2020 after selling out during the quarter.
1834 Investment Advisors sold 36 Medifast shares in Q3 2020, an estimated $5K.
1834 Investment Advisors first reported a position in Medifast in Q2 2020 and held it in 1 quarter.
1834 Investment Advisors's Medifast position peaked at $5K in Q2 2020.
240 funds tracked by Wall St. Rank held Medifast as of Q3 2020.

Based on 1834 Investment Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.